2002
Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis
Finkelstein ES, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. American Journal Of Kidney Diseases 2002, 39: 1278-1286. PMID: 12046042, DOI: 10.1053/ajkd.2002.33403.Peer-Reviewed Original ResearchConceptsLong-term peritoneal dialysisEpisodes of infectionPeritoneal dialysisCatheter changeRepeat infectionsLong-term peritoneal dialysis (PD) therapyMultiple episodesEnd-stage renal diseaseCause of peritonitisPeritoneal dialysis therapyAntibiotic sensitivity patternCulture-positive peritonitisPattern of infectionSpearman correlation testPeritonitis episodesSubsequent peritonitisPeritoneal catheterRenal diseaseDialysis therapyCausative organismPeritonitisPatientsSensitivity patternSame organismInfection
1991
Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice.
Colson ER, Horwitz RI, Bia FJ, Viscoli CM. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice. JAMA Internal Medicine 1991, 151: 709-13. PMID: 2012453, DOI: 10.1001/archinte.151.4.709.Peer-Reviewed Original ResearchConceptsZidovudine therapyDosage reductionAdverse outcomesHuman immunodeficiency virus type 1 (HIV-1) infectionClinical practiceHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Observational cohort studyHuman immunodeficiency virusTreatment of patientsType 1 infectionVirus type 1Zidovudine dosageCohort studyMost patientsImmunodeficiency virusBaseline cytopeniasTreatment outcomesPatterns of usePatientsTherapyType 1Dosage changesMonths